Over the last few years, Georgetown University has seen these successful ventures and partnerships arising from innovative work of its first-rate faculty and research personnel. Here are a few of our notable successes:
BioMetrx™ is a drug discovery and development company dedicated to significantly improving the clinical outcomes for advanced prostate, colorectal, and breast cancer patients.
In January 2012, Georgetown licensed worldwide rights of the theranostic Rasstore™ to Biometrx. Rasstore is named for the novel way it could potentially restore the body’s natural ability to suppress tumor cells, utilizing the tumor suppressor gene RASSF1A. The agent was invented by Milton Brown, M.D., Ph.D., director of GUMC’s Drug Discovery Program, and Partha Banerjee, Ph.D., a world recognized expert on RASSF1A and tumor suppression, also at GUMC.
(from MyCareTeam website)
MyCareTeam, Inc. was founded to provide software tools that are designed to help people with chronic diseases manage their illnesses and reduce overall healthcare costs. The company’s software offering currently provides disease management & monitoring in the key health areas of diabetes, weight management and hypertension.
For more information about Georgetown's portfolio and our inventions, please contact our office via techlicensing [at] georgetown [dot] edu or call our office at 202-687-7424.